Novel mechanism of the COVID-19 associated coagulopathy (CAC) and vascular thromboembolism
Description
Previous studies from our laboratory revealed that SARS-CoV-2 spike protein (SP) administration to a genetically engineered model expressing the human angiotensin-converting enzyme 2; ACE2 receptor (i.e., hACE2 humanized mouse) mimicked the